Followers | 6 |
Posts | 2155 |
Boards Moderated | 0 |
Alias Born | 11/26/2014 |
Tuesday, April 25, 2017 11:09:28 AM
Other income generation that would really help is approval of Pristiq and Lamictal. There is a strong possibility that one or both of these gets approved in 2017.
I personally believe Gluco will be partnered. As has been pointed out, the cost per pill is very low, so that means means margins are low. I do not think Gluco is a good fit for IPCI to manufacture. I could be wrong but it seems you would need a very efficient operation to manufacture this product and make money. That limits the scope of potential partners. Like I said, I think they will partner but I am guessing the revenue generated by this product will be low.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM